Yolanda Wang

Popular Topics

Intellectual Property Food, Drugs, Healthcare, Life Sciences

Yolanda Wang’s articles from Eagle IP are most popular:

with Inhouse Counsel
with readers working within the Law Firm industries
within Intellectual Property topic(s)
in China, Asia and Africa

DETAILS

China

www.eagle-ip.com

AUTHORS CONTENT

IP Update: China’s Supreme People’s Court Issues First Public Decision Defining China’s Inventorship Standard

Breaking: China Released Drug Trial Data Protection Implementation Measures

China Healthcare

A Stratification Too Far? How The CNIPA Draws The Line On Patient Subgroups In A Recent Precision Medicine Invalidation Case

Please “Mind The Traps”: Four Common Misconceptions About Hong Kong Patents

The Secret Prior Art Trap: A Case Study On Conflicting Applications In China

From Faces To Football Fields: How Applying AI Models To Different Application Fields Can Prove Inventive In China

When Standards Evolve: How China Judges Inventiveness In Next-Gen Tech Patents

Obviousness: Can Features From Different Categories Of Products Be Combined To Invalidate A Design Patent?

RNAi Patent Success In China: Overcoming "Comprising" Claim Challenges

Burden Shift: CNIPA Requires Applicant To "Prove" That Post-Filing Data Is Not Fake Data

AI Is Magical But NOT Magic! Be Specific In Your AI Patents!

How A Secondhand Ground Brush Wiped Away A Chinese Patent

How To Protect A Crystal Form (Polymorph) Patent In China

Why Do Examiners Fail To Recognize The Importance Of My "Parameter Features"?

A Stratification Too Far? How The CNIPA Draws The Line On Patient Subgroups In A Recent Precision Medicine Invalidation Case

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More